This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Apr 9;372(6538):127-128.

doi: 10.1126/science.abh3188.

Epigenetic nucleotides enhance therapy

Skirmantas Kriaucionis¹

Affiliations

PMID: 33833109
DOI: 10.1126/science.abh3188

Comment

Epigenetic nucleotides enhance therapy

Skirmantas Kriaucionis. Science. 2021.

. 2021 Apr 9;372(6538):127-128.

doi: 10.1126/science.abh3188.

Author

Skirmantas Kriaucionis¹

Affiliation

¹ Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK. skirmantas.kriaucionis@ludwig.ox.ac.uk.

PMID: 33833109
DOI: 10.1126/science.abh3188

No abstract available

PubMed Disclaimer

Comment on

Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors.
Fugger K, Bajrami I, Silva Dos Santos M, Young SJ, Kunzelmann S, Kelly G, Hewitt G, Patel H, Goldstone R, Carell T, Boulton SJ, MacRae J, Taylor IA, West SC. Fugger K, et al. Science. 2021 Apr 9;372(6538):156-165. doi: 10.1126/science.abb4542. Science. 2021. PMID: 33833118 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

BB/M001873/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations